Background: Cells release extracellular membrane vesicles including microvesicles known
INTRODUCTION
Cancer cells are capable of promoting pro-tumorigenic features such as angiogenesis through paracrine signalling which can potentially promote metastases [1] . In addition to release of soluble proteins, multiple cell types including colorectal cancer cells have been shown to release a variety of extracellular membrane vesicles including microvesicles known as exosomes. Exosomes are lipid vesicles with a diameter of 40-100nm which are highly stable, facilitating collection from various body fluids as well as cell culture media [2] . They are known to contain lipids, DNA and RNA and have recently been recognised as vehicles capable of facilitating intercellular communication [3] . Emerging evidence indicates that exosomes may play a role in a range of biological processes through transfer of their contents from donor cells to recipient cells [4] . In cancer, exosomes also play a significant role with evidence showing a pro-tumorigenic effect associated with the transfer of protein content [5] .
One of the most exciting aspects of exosomes involvement in cancer is that they have recently been found to contain miRNAs [6] .
miRNAs are a class of small non-coding RNA molecules 19-25 nucleotides in length. miRNAs regulate gene expression at a post transcriptional level leading to the inhibition of mRNA translation or mRNA degradation [7] . Functional studies have shown miRNAs to participate in almost every cellular process including apoptosis, proliferation and differentiation [7, 8] . Some miRNAs are dysregulated in the tissues and circulation of CRC patients making them promising as biomarkers [8, 9] . Recent studies, however, have reported a number of miRNAs believed to be released by colorectal tumours as circulating markers of disease are expressed by red blood cells and may be present in the plasma and serum secondary to haemolysis [10] . Tumour derived exosomal miRNAs may provide a more specific miRNA signature advancing the potential of early detection and individualised treatments [11, 12] .
Recent studies have shown exosomes are capable of delivering chemotherapeutic agents in vitro and can deliver anti-tumour miRNAs to breast cancer cells and prostate cancer cells when injected systemically in vivo or directly into tumours [13] [14] [15] . Identification of potent tumour suppressor miRNAs in CRC is useful for development of therapeutics in this regard.
miR-379 has previously been identified as a tumour suppressor in breast cancer [16] . A genome wide analysis of miRNAs imprinted on the 14q32.31 locus including miR-379 reveals downregulation of these miRNAs in human cancers indicating this entire miRNA cluster is a locus of tumour-suppressors [17] . These data, taken in conjunction with previous studies showing compelling evidence that miR-379 is a tumour suppressor in breast cancer, indicate miR-379 is an ideal candidate for further investigation in CRC. This study aimed to firstly identify the full range of miRNAs packaged into exosomes and secreted by two CRC cell lines with different phenotypical characteristics. The effect of miR-379 in CRC cells and its potential to be transferred to recipient cells in exosomes was also examined.
METHODS

Cell Lines and Culture Conditions
HCT-116 and HT-29 CRC cells were purchased from the American Type Culture Collection (Manassas, VA, USA). Cell lines were last authenticated in May 2014 using DNA fingerprinting. Cells were cultured in McCoys-5A media supplemented with 10% fetal bovine serum (FBS) and 100U/ml penicillin/ 100 µg streptomycin (P/S). Cells were incubated at 37 0 C and 5% CO 2.
Isolation of CRC Cell Secreted Exosomes
To prepare exosome-free media, exosomes were removed from FBS. FBS was centrifuged at 300 x g for 10 minutes followed by 2000 x g for 10 minutes to remove cellular debris. The supernatant was then passed through a 0.2µm sterile filter. Exosomes were separated from the supernatant by ultracentrifugation at 110,000 x g at 4°C for 70 minutes. After ultracentrifugation the exosome free FBS supernatant was collected.
For exosome isolation, 2 x 10 6 cells were seeded into T-175 flasks containing 17 mLs of preprepared exosome free culture medium and cultured for 48 hours. A process of differential centrifugation, passage through a microfilter and ultra-centrifugation was performed to isolate exosomes [6] . In detail, following 48 hours incubation the media containing exosomes 
Transmission Electron Microscopy
HCT-116 and HT-29 exosomes were isolated as previously described. A primary fixative (2% Glutaraldehyde, 2% Paraformaldehyde in a 0.1M Sodium Cacodylate/HCL buffer at a pH of 7.2) was added to exosome containing media prior to the final ultracentrifugation step.
Exosomes were re-suspended in 50µL of PBS and treated with a secondary fixative (1% Osmium Tetroxide). The resultant exosome pellet was subsequently dehydrated with graded alcohol and then incubated in resin in a 65°C oven. The resin block was trimmed using an ultramicrotome to sections of 80-100nm thickness (Reichert-Jung Ultracut E). Slices were loaded onto a copper grid and stained with 1.5% aqueous uranyl acetate followed by lead citrate. Viewing was performed with a Hitcachi H7000 Transmission Electron Microscope.
Western Blotting
HCT-116 and HT-29 secreted exosomes were collected as previously described. After ultracentrifugation, exosomes were re-suspended in Triton-X lysis buffer [150mM NaCl, 20 mM HEPES, 2 mM EDTA, 1% Triton-X100, 2mM Sodium Orthovanadate, 10mM Sodium
Fluoride, 10ul/mL Protease inhibitor cocktail (Fisher Scientific)] and frozen at -20°C. Protein content was determined using the Micro BCA™ Protein Assay Kit (Thermo Scientific).
Protein (100µg) was reduced in DTT (0.5 M) for 10 minutes at 70°C and samples run on a 4-15% gradient pre-cast Mini-PROTEAN® TGX™ Gels (Bio-Rad) for 60 minutes at 100V.
Protein molecular weight standards (20-220 kDa) were run simultaneously on each gel.
Electroblotting was performed for 60 minutes at 100V to transfer protein samples to a nitrocellulose membrane. Blots were blocked in 5% milk in TBS-T for 1 hour, and probed with an antibody targeting CD63 (1:1,000; Abcam) overnight and washed in TBS-T.
Horseradish peroxidase labelled goat anti-rabbit (1:3,000; Abcam) secondary antibody was then added to the membranes for 1.5 hours. Following washing steps, SuperSignal West Dura Chemiluminescent substrate (Thermo Scientific) was applied to the membranes for 5 minutes. Images were captured using a Syngene G-Box and GeneSnap software.
RNA extraction and microRNA array
RNA was extracted from exosomes using the mirVana TM miRNA isolation kit following manufacturer's instructions. The Nanodrop TM Spectrophotometer (Thermo Scientific) was used to assess RNA present. Samples extracted from HCT-116 and HT-29 exosomes were then delivered to Exiqon Services, Denmark. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile. All RNA from sample and artificial reference was labeled with Hy3™ and Hy5™ fluorescent label, respectively, using the miRCURY LNA™ Instruction manual. The miRCURY LNA™ microRNA Array slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and image analysis was carried out using the ImaGene 9.0 software (BioDiscovery, Inc., USA). The quantified signals were background corrected [19] and normalized using quantile normalization method. Technical quality assessment was performed based on results from spike in controls in the array. miRNAs above a certain threshold were considered present.
The background threshold was calculated for each individual microarray slide as 1.2 times the 25th percentile of the overall signal intensity of the slide. Expression levels were then calculated on a scale from 0-10 and those with levels less than 4 were deemed undetectable.
Target validation using RQ-PCR
Exosomal miRNAs of interest were reverse transcribed using the MultiScribe™-based High- as mean +/-SEM. P values were calculated using ANOVA.
Migration Assays
To assess the effect of miR-379 on cell migration, Transwell® Permeable Supports (Corning 
RESULTS
Exosome characterisation
Microvesicles with a spherical morphology ranging in size between 40 and 100 nm consistent with exosomes were found to be secreted by both cell lines and successfully visualised with TEM ( Figure 1A ). Western Blot for the exosome-associated protein CD63 revealed a characteristic band between 50-60 kDa in size ( Figure 1B ).
Identification of exosomal microRNA content
Expression analysis revealed the number of miRNAs present in the exosomes of both CRC cell lines to be within the expected range for human samples. 409 miRNAs were detected above threshold in HT-29 derived exosomes. 393 miRNAs were detected in HCT116 exosomes, with 338 miRNAs common to exosomes from both HCT-116 and HT-29 cells.
The 20 most highly expressed miRNAs in HCT-116 cell secreted exosomes and HT-29 cell secreted exosomes were identified ( Table 1 ). The miRNAs which were found to have the highest difference in expression levels between the exosomes secreted by either HCT-116 or HT-29 cell lines were also identified ( Table 2) .
Validation of selected array data by qRT-PCR
Selected miRNAs (miR-10b, miR-143 and miR-149-5p) were validated in three separate exosome isolates from both HCT-116 and HT-29 cell secreted exosomes. miR-10b, miR143
and miR-149-5p were consistently detectable in exosome extracts from both cell lines. miR- 
Transfer of exosomes between cell populations and functional effects
Exosomes with a red fluorescing protein were isolated from miR-379 over-expressing cells. Previous studies have identified selected miRNAs present in exosomes secreted by CRC cells in vitro [11] . A number of miRNAs have also been identified in exosomes isolated from the circulation of CRC patients [12] . This is the first study to describe the full range of miRNAs present in both HCT-116 and HT-29 CRC cell secreted exosomes, demonstrating a large range of miRNAs some of which have well described roles in cancer pathogenesis, and others which have only recently been discovered. Among the most highly expressed miRNAs in both CRC cell line exosomes are several which have previously described roles in gastrointestinal cancers (miR-10b-3p, let7b-5p, miR-378c, miR-145-5p) [21] [22] [23] [24] . In addition, included in the most highly expressed are some miRNAs with little or no available data regarding their association with disease states, associated gene targets or functional roles.
These miRNAs may represent new targets as biomarkers worthy of further investigation.
miR-10b was found to be among the most highly expressed miRNAs in both CRC cell line exosomes and was validated in multiple exosome samples. High levels of miR-10b have been associated with a higher incidence of lymphatic invasion and poor prognosis in CRC tissues [25] . Interestingly, exosome-mediated transfer of miR-10b to recipient non-invasive breast cancer cell lines has been shown to promote cell invasion in breast cancer [26] . miR-143 and miR-149-5p were also validated. These miRNAs were not among the most highly expressed but the fact that they are detectable in multiple exosome isolated from both CRC cell lines indicates validity of array data.
miR-379 down-regulates several genes involved in the TGF-β signalling pathway and a large proportion of CRCs are known to display abnormalities in TGF-β pathway factors [27, 28] . A significant reduction in colorectal cancer cell proliferation in response to over-expression of miR-379 was observed. Cells over expressing miR-379 were found to proliferate between 12-15% slower compared to controls. A marked reduction in migration of CRC cells in response to over-expression of miR-379 was observed ranging as high as an 86%. This effect is interesting as miR-379 has a documented effect on cyclin B1. Cyclin B1 in turn has a documented inhibitory effect on E-cadherin leading to induction of CRC cell migration and invasion which is contrary to the effect observed in this study and worthy of further investigation [28] . Exosomes which were secreted from miR-379 over-expressing cells were Table 1 Title: The 20 most highly expressed miRNAs in HCT-116 and HT-29 cell secreted exosomes.
(Complete dataset available at www.microvesicles.org. Experiment ID -Vesiclepedia_557)
[29] Table 2 Title: The 10 most differentially expressed miRNAs contained within exosomes secreted by both cell lines (the miRNAs with the most significant difference in expression in one cell line compared to another) 
